LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
SK-BR-3 PD0325901
10.0
uM
LJP5
 0.4997 0.0404 0.1587 0.1119
SK-BR-3 PD0325901
10.0
uM
LJP6
 0.5194 0.0218 0.2014 0.0393
SK-BR-3 PD173074
10.0
uM
LJP6
 0.5135 0.0299 0.1836 0.0977
SK-BR-3 PD184352
10.0
uM
LJP5
 0.7598 0.0116 0.6008 0.0219
SK-BR-3 Pelitinib
10.0
uM
LJP5
 0.2784 0.0110 -0.2014 0.0612
SK-BR-3 PF431396
10.0
uM
LJP5
 0.3225 0.0290 -0.1319 0.1011
SK-BR-3 PF477736
10.0
uM
LJP5
 0.3021 0.0414 -0.1657 0.1139
SK-BR-3 PF562271
10.0
uM
LJP6
 0.2716 0.0420 -0.2193 0.1319
SK-BR-3 PHA-665752
10.0
uM
LJP5
 0.4147 0.1854 0.0572 0.2740
SK-BR-3 PHA-793887
10.0
uM
LJP6
 0.2470 0.0261 -0.2588 0.1116
SK-BR-3 PI103
10.0
uM
LJP6
 0.3289 0.0250 -0.1204 0.0914
SK-BR-3 PLX-4720
10.0
uM
LJP5
 0.5538 0.0597 0.2445 0.1426
SK-BR-3 QL-X-138
10.0
uM
LJP6
 0.2820 0.0308 -0.2006 0.1132
SK-BR-3 QL-XII-47
10.0
uM
LJP6
 0.2506 0.0390 -0.2463 0.0760
SK-BR-3 Radicicol
10.0
uM
LJP5
 0.3320 0.0431 -0.1050 0.0092
SK-BR-3 Radicicol
10.0
uM
LJP6
 0.2925 0.0398 -0.1715 0.0078
SK-BR-3 Seliciclib
10.0
uM
LJP5
 0.4811 0.0495 0.1359 0.0912
SK-BR-3 Ruxolitinib
10.0
uM
LJP5
 0.8889 0.0697 0.8183 0.1169
SK-BR-3 XL147
10.0
uM
LJP5
 0.7950 0.0414 0.6508 0.0855
SK-BR-3 Saracatinib
10.0
uM
LJP6
 0.5084 0.0123 0.1803 0.0550
SK-BR-3 Selumetinib
10.0
uM
LJP6
 0.9633 0.0150 0.9360 0.0276
SK-BR-3 Sirolimus
10.0
uM
LJP6
 0.5933 0.0049 0.3211 0.0480
SK-BR-3 Sorafenib
10.0
uM
LJP6
 0.5179 0.0603 0.1855 0.1413
SK-BR-3 SU11274
10.0
uM
LJP5
 0.3994 0.0288 0.0045 0.0118
SK-BR-3 Fedratinib
10.0
uM
LJP5
 0.2926 0.0158 -0.1775 0.0604